Table 1.
Characteristics | N | % |
---|---|---|
Lineage | ||
L4 | 16,687 | 46.6 |
L2 | 10,365 | 29.0 |
L3 | 5038 | 14.1 |
L1 | 3266 | 9.1 |
Others | 421 | 1.1 |
World Health Organization Region | ||
Europe | 13,381 | 37.4 |
Africa | 8756 | 24.5 |
South East Asia | 5518 | 15.4 |
Western Pacific | 3964 | 11.1 |
Americas | 3176 | 8.9 |
Other | 982 | 2.8 |
Genotypic drug-resistance | ||
MDR-TB | 433 | 1.2 |
Pre XDR-TB | 4034 | 11.3 |
XDR-TB | 2156 | 6.0 |
Susceptible | 18,378 | 51.3 |
Other | 10,776 | 30.2 |
MDR Multidrug-Resistant TB, Pre-XDR Pre-Extensively Drug-resistant TB, XDR Extensively Drug-resistant TB.